155 related articles for article (PubMed ID: 28117203)
1. Benzoflavones as cholesterol esterase inhibitors: Synthesis, biological evaluation and docking studies.
Singh H; Singh JV; Gupta MK; Singh P; Sharma S; Nepali K; Bedi PMS
Bioorg Med Chem Lett; 2017 Feb; 27(4):850-854. PubMed ID: 28117203
[TBL] [Abstract][Full Text] [Related]
2. 5,6-Benzoflavones as cholesterol esterase inhibitors: synthesis, biological evaluation and docking studies.
Singh JV; Kaur A; Bhagat K; Gupta MK; Singh M; Singh H; Bedi PMS
Medchemcomm; 2018 Mar; 9(3):490-502. PubMed ID: 30108939
[TBL] [Abstract][Full Text] [Related]
3. Structure-reactivity relationships for the inhibition mechanism at the second alkyl-chain-binding site of cholesterol esterase and lipase.
Lin G; Shieh CT; Ho HC; Chouhwang JY; Lin WY; Lu CP
Biochemistry; 1999 Aug; 38(31):9971-81. PubMed ID: 10433704
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of phosphorylated flavonoids as potent and selective inhibitors of cholesterol esterase.
Wei Y; Peng AY; Wang B; Ma L; Peng G; Du Y; Tang J
Eur J Med Chem; 2014 Mar; 74():751-8. PubMed ID: 23601990
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of 2-(1H-indol-3-yl)-4-phenylquinolines as inhibitors of cholesterol esterase.
Muscia GC; Hautmann S; Buldain GY; Asís SE; Gütschow M
Bioorg Med Chem Lett; 2014 Mar; 24(6):1545-9. PubMed ID: 24556381
[TBL] [Abstract][Full Text] [Related]
6. Identification and synthesis of selective cholesterol esterase inhibitor using dynamic combinatorial chemistry.
Zhao S; Wu Y; Hu L
Bioorg Chem; 2022 Feb; 119():105520. PubMed ID: 34864280
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory Effect of Condensed Tannins from Banana Pulp on Cholesterol Esterase and Mechanisms of Interaction.
Li X; Jiang H; Pu Y; Cao J; Jiang W
J Agric Food Chem; 2019 Dec; 67(51):14066-14073. PubMed ID: 31762280
[TBL] [Abstract][Full Text] [Related]
8. Phosphaisocoumarins as a new class of potent inhibitors for pancreatic cholesterol esterase.
Li B; Zhou B; Lu H; Ma L; Peng AY
Eur J Med Chem; 2010 May; 45(5):1955-63. PubMed ID: 20149492
[TBL] [Abstract][Full Text] [Related]
9. Molecular recognition by cholesterol esterase of active site ligands: structure-reactivity effects for inhibition by aryl carbamates and subsequent carbamylenzyme turnover.
Feaster SR; Lee K; Baker N; Hui DY; Quinn DM
Biochemistry; 1996 Dec; 35(51):16723-34. PubMed ID: 8988009
[TBL] [Abstract][Full Text] [Related]
10. New cholesterol esterase inhibitors based on rhodanine and thiazolidinedione scaffolds.
Heng S; Tieu W; Hautmann S; Kuan K; Pedersen DS; Pietsch M; Gütschow M; Abell AD
Bioorg Med Chem; 2011 Dec; 19(24):7453-63. PubMed ID: 22075233
[TBL] [Abstract][Full Text] [Related]
11. Identification and molecular docking study of novel cholesterol esterase inhibitory peptides from camel milk proteins.
Mudgil P; Baby B; Ngoh YY; Vijayan R; Gan CY; Maqsood S
J Dairy Sci; 2019 Dec; 102(12):10748-10759. PubMed ID: 31548068
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of tricyclic 1,3-oxazin-4-ones and kinetic analysis of cholesterol esterase and acetylcholinesterase inhibition.
Pietsch M; Gütschow M
J Med Chem; 2005 Dec; 48(26):8270-88. PubMed ID: 16366609
[TBL] [Abstract][Full Text] [Related]
13. Discovery of potential pancreatic cholesterol esterase inhibitors using pharmacophore modelling, virtual screening, and optimization studies.
John S; Thangapandian S; Sakkiah S; Lee KW
J Enzyme Inhib Med Chem; 2011 Aug; 26(4):535-45. PubMed ID: 21143043
[TBL] [Abstract][Full Text] [Related]
14. A new synthesis of fully phosphorylated flavones as potent pancreatic cholesterol esterase inhibitors.
Peng G; Du Y; Wei Y; Tang J; Peng AY; Rao L
Org Biomol Chem; 2011 Apr; 9(7):2530-4. PubMed ID: 21340062
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of a new series of tri-, di-, and mono-N-alkylcarbamylphloroglucinols as conformationally constrained inhibitors of cholesterol esterase.
Lin MC; Lin GZ; Hwang CI; Jian SY; Lin J; Shen YF; Lin G
Protein Sci; 2012 Sep; 21(9):1344-57. PubMed ID: 22811279
[TBL] [Abstract][Full Text] [Related]
16. Bridging of a substrate between cyclodextrin and an enzyme's active site pocket triggers a unique mode of inhibition.
Sule NV; Ugrinov A; Mallik S; Srivastava DK
Biochim Biophys Acta; 2015 Jan; 1850(1):141-9. PubMed ID: 25450177
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, biological evaluation, and molecular docking studies of xanthone sulfonamides as ACAT inhibitors.
Li X; Zou Y; Zhao Q; Yang Y; Wu M; Huang T; Hu H; Wu Q
Chem Biol Drug Des; 2015 Mar; 85(3):394-403. PubMed ID: 25146964
[TBL] [Abstract][Full Text] [Related]
18. Carboxylated aurone derivatives as potent inhibitors of xanthine oxidase.
Muzychka OV; Kobzar OL; Popova AV; Frasinyuk MS; Vovk AI
Bioorg Med Chem; 2017 Jul; 25(14):3606-3613. PubMed ID: 28545814
[TBL] [Abstract][Full Text] [Related]
19. Potential human cholesterol esterase inhibitor design: benefits from the molecular dynamics simulations and pharmacophore modeling studies.
John S; Thangapandian S; Lee KW
J Biomol Struct Dyn; 2012; 29(5):921-36. PubMed ID: 22292952
[TBL] [Abstract][Full Text] [Related]
20. Enantiomeric inhibitors of cholesterol esterase and acetylcholinesterase.
Lin G; Tsai YC; Liu HC; Liao WC; Chang CH
Biochim Biophys Acta; 1998 Oct; 1388(1):161-74. PubMed ID: 9774723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
